Access & coverage
Tax-funded + private optional
Public system + Pharmac drug agency; private optional
Treatment
- Symptomatic drugs (cholinesterase inhibitors, levodopa, etc.)
- Memory clinics / neurology pathways
- Long-term care + home supports more than cure
Prevention
- Vascular risk-factor control (for vascular dementia / stroke sequelae)
- Hearing care, social engagement, midlife BP control (dementia risk)
- Fall prevention in older adults
Lifestyle
- Cognitive / social activity; Mediterranean-style diet patterns
- Exercise; treat sleep apnea and hearing loss
- Caregiver support to delay institutionalization
What stands out here
Same broad neurologic toolkit as peers — differences are coverage rules, wait times, prices, and follow-through.
vs master: -0.0 percentage points vs Top 20 average share.